6254 — Nomura Micro Science Co Balance Sheet
0.000.00%
- ¥89bn
- ¥125bn
- ¥73bn
- 37
- 36
- 34
- 25
Annual balance sheet for Nomura Micro Science Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 4,845 | 9,861 | 10,083 | 14,120 | 12,142 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 10,309 | 10,169 | 11,053 | 17,004 | 39,225 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 16,836 | 21,380 | 23,361 | 37,180 | 65,505 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,771 | 1,836 | 1,923 | 2,917 | 3,058 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 19,622 | 24,759 | 27,091 | 41,919 | 70,603 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8,775 | 11,128 | 10,720 | 20,044 | 41,281 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 9,307 | 11,568 | 11,159 | 20,518 | 41,679 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 10,315 | 13,190 | 15,932 | 21,401 | 28,924 |
Total Liabilities & Shareholders' Equity | 19,622 | 24,759 | 27,091 | 41,919 | 70,603 |
Total Common Shares Outstanding |